1 follower

Samumed is a leader in medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.






Org chart

Osman Kibar

Amy Halseth
Executive Director, Clinical Science
Arman Oruc
Chief Legal Officer
Cevdet Samikoglu
President & Chief Financial Officer
Christopher Swearingen
VP, Clinical Outcomes and Analytics
Erich Horsley
Chief Business Officer
Gary Choy
VP, Marketing
Jeymi Tambiah
SVP, Medical Affairs
Mark Fineman
SVP, Clinical Development
Michael A. White
Chief Scientific Officer
Neil Bair
VP, Market Access
Scott W. Bulcao
VP, Administrative Operations & Assistant General Counsel
Steve Svitenko
VP, Commercial Head, Musculoskeletal
Thomas Bicsak
VP, Regulatory Affairs
Yusuf Yazici
Chief Medical Officer
Darrin M. Beaupre
Chief Medical Officer, Oncology
Morton Sanger
Chief Scientific Officer
Hadi Falahatpisheh
Head, Translational Sciences